Drug screening is a type of test carried out to determine an individual’s scope and degree of drug abuse. The global drug screening market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7% from 2017 to 2023. Drug testing is mandated imperative by many organizations and institutes to maintain an addiction free and sober workforce. Healthy and sober workforce helps maintain high productivity and a proper work environment. Special rules are issued by government regarding use of drug abuse in public places such as railway stations, airports etc. to ensure safety of local population. Use of performance enhancement drugs often termed as ‘doping’ is increasing problem in professional sports which is regulated by international sports organizations by establishing rules and prohibiting drugs. Research Beam Model: Research Beam Product ID: 2019226 5370 USD New
Global Drug Screening Market by Product & Services [Equipment (Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers {Semiconductor Breath Analyzers, Fuel Cell Analyzers}, Rapid Testing Devices(RTD) {Oral Fluid Testing Devices, Urine Testing Devices}), Consumables {Assay Kits, Calibrators & Controls, Sample Collection Cups} and Laboratory Services], by Sample Type [Oral Fluid/Saliva, Breath, Hair, Other Samples {Blood & Sweat}], by End User [Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Global Drug Screening Market by Product & Services [Equipment (Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers {Semiconductor Breath Analyzers, Fuel Cell Analyzers}, Rapid Testing Devices(RTD) {Oral Fluid Testing Devices, Urine Testing Devices}), Consumables {Assay Kits, Calibrators & Controls, Sample Collection Cups} and Laboratory Services], by Sample Type [Oral Fluid/Saliva, Breath, Hair, Other Samples {Blood & Sweat}], by End User [Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers] - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : August  2017
  • Pages : 212
 
 

Drug screening is a type of test carried out to determine an individual’s scope and degree of drug abuse. The global drug screening market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7% from 2017 to 2023. Drug testing is mandated imperative by many organizations and institutes to maintain an addiction free and sober workforce. Healthy and sober workforce helps maintain high productivity and a proper work environment. Special rules are issued by government regarding use of drug abuse in public places such as railway stations, airports etc. to ensure safety of local population. Use of performance enhancement drugs often termed as ‘doping’ is increasing problem in professional sports which is regulated by international sports organizations by establishing rules and prohibiting drugs.

Technological advancements in drug screening devices and upsurge in applications of these devices in market drives the drugs screening market. Moreover, increase in alcohol consumption and illicit use of prescribed drugs by ageing population, increase in government funding for drug testing programs augment market growth. However, the fact that drug testing is considered as a violation right in some countries, precision and accuracy issues regarding breath analyzers, ban on alcohol consumption in various countries restrain the market growth. The use of advanced technology in the drug testing devices and untapped emerging economies offer lucrative opportunities for the market players. 

The global drug screening market is segmented based on equipment and services, sample type, end user, and geography. Based on equipment and services, the market is segmented into equipment, rapid testing devices, consumables and laboratory services. Equipment segment is further bifurcated by type into immunoassay analyzers, chromatography instruments and breath analyzers.  Breath analyzer are further divided into fuel cell analyzers, semiconductor analyzers and other devices.  Rapid testing devices are divided into oral fluid testing devices and urine testing devices. Consumables segment is further bifurcated into assay kits, calibrators and controls, samples collection cups and other materials such as gloves, cotton swabs, syringes and others.

Based on sample type, this market is bifurcated into urine, oral fluid/saliva, breath, hair and others (blood and sweat). Urine sample test is widely used as this sample can be collected without causing any pain to the patient and is one of the most convenient detection method. Thus, urine sample screening tests held a major share in this segment in the year 2015 and this trend is likely to continue over the forecast period. Hair sample is expected to grow at a remarkable CAGR and is the fastest growing segment in drug screening market.

Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the drug screening market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of drug screening in this region. However, Asia-Pacific is expected to emerge as a lucrative area with significant growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

KEY MARKET BENEFITS

  •  The study provides an in-depth analysis of the global drug screening market, with current trends and future estimations to elucidate the imminent investment pockets.
  •  A quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities is discussed.
  •  Key market players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the market.
  •  Porters Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

KEY PLAYERS PROFILED

  •  Alere, Inc.
  •  Drägerwerk AG & Co. KGAA
  •  Abbott Laboratories
  •  Hoffmann-La Roche AG
  •  Biorad Laboratories, Inc.
  •  Siemens AG
  •  Thermo Fisher Scientific, Inc.
  •  Danaher Corporation
  •  Quest Diagnostics Incorporated
  •  Express Diagnostics International Inc.

KEY MARKET SEGMENTS:

 By Product & Service

  •  Equipment
    •  Immunoassay Analyzers
    •  Chromatography Instruments
    •  Breath Analyzers
      •  Fuel Cell Breathlyzers
      •  Semiconductor Breathlyzers
      •  Other Devices
  •  Rapid Testing Devices
    •  Urine Testing Devices
      •  Urine Testing Cups
      •  Dip Cards
      •  Cassettes
    •  Oral Fluid Testing Devices
  •  Consumables
    •  Assay Kits
    •  Sample Collection Cups
    •  Calibrators and Controls
    •  Others
  •  Laboratory Services

 By Sample Type

  •  Urine Sample
  •  Breath Sample
  •  Oral Fluid Sample
  •  Hair Sample
  •  Others (Blood and Sweat Samples)

 By End User

  •  Workplace and Schools
  •  Drug Testing Laboratories
  •  Criminal Justice System & Law Enforcement Agencies
  •  Hospitals
  •  Drug Treatment Centers
  •  Pain Management Centers
  •  Personal Users

 By Geography

  •  North America
    •  U.S.
    •  Canada
    •  Mexico
  •  Europe
    •  Germany
    •  France
    •  UK
    •  Italy
    •  Spain
    •  Rest of Europe
  •  Asia-Pacific
    •  Japan
    •  China
    •  Australia
    •  India
    •  South Korea
    •  Taiwan
    •  Rest of Asia-Pacific
  •  LAMEA
    •  Brazil
    •  Turkey
    •  Saudi Arabia
    •  South Africa
    •  Rest of LAMEA

Other players in the value chain include (profiles not included in the report)

  •  BioMerieux
  •  Shimadzu
  •  CannAmm Occupational Testing Services 
  •  Agilent Technologies
  •  DiaSorin
  •  Eiken
  •  Merck
  •  Fujirebio
  •  Synergy Health PL.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. PATENT ANALYSIS.

3.4.1. Patent analysis, by year (2010-2016)
3.4.2. Patent analysis, by region

3.5. REGULATIONS
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Stringent government regulations regarding drug abuse
3.6.1.2. Rise in awareness against drug abuse
3.6.1.3. Surge in funding for drug screening

3.6.2. Restraints

3.6.2.1. Consideration of drug screening as a violation of rights
3.6.2.2. Possible manipulation of drug screening tests

3.6.3. Opportunities

3.6.3.1. Development of novel drug screening tests
3.6.3.2. Tapping the emerging markets

CHAPTER 4 DRUG SCREENING MARKET, BY PRODUCT & SERVICE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. EQUIPMENT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Immunoassay analyzers

4.2.4.1. Market size & forecast

4.2.5. Chromatography instruments

4.2.5.1. Market size and forecast

4.2.6. Breath analyzers

4.2.6.1. Semiconductor breath analyzers
4.2.6.2. Fuel cell analyzers
4.2.6.3. Market size and forecast

4.3. RAPID TESTING DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Urine testing devices

4.3.3.1.1. Market size and forecast
4.3.3.1.2. Urine testing cups (value and volume estimation)
4.3.3.1.3. U.S.

4.3.3.1.3.1.1. Market size and forecast
4.3.3.1.3.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.4. Canada

4.3.3.1.4.1.1. Market size and forecast
4.3.3.1.4.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.5. UK

4.3.3.1.5.1.1. Market size and forecast
4.3.3.1.5.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.6. Taiwan

4.3.3.1.6.1.1. Market size and forecast
4.3.3.1.6.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.7. Dip cards
4.3.3.1.8. Cassettes

4.3.3.2. Oral fluid testing devices

4.3.3.2.1. Market size and forecast

4.4. CONSUMABLES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Assay kits

4.4.4.1. Market size and forecast

4.4.5. Sample collection cups

4.4.5.1. Market size and forecast

4.4.6. Calibrators and controls

4.4.6.1. Market size and forecast

4.4.7. Others

4.4.7.1. Market size and forecast

4.5. LABORATORY SERVICES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 DRUG SCREENING MARKET, BY SAMPLE TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. URINE

5.2.1. Market size and forecast

5.3. ORAL FLUID

5.3.1. Market size and forecast

5.4. BREATH

5.4.1. Market size and forecast

5.5. HAIR

5.5.1. Market size and forecast

5.6. OTHER SAMPLES (BLOOD AND SWEAT)

5.6.1. Market size and forecast

CHAPTER 6 DRUG SCREENING MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. WORKPLACES AND SCHOOLS

6.2.1. Market size and forecast

6.3. CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES

6.3.1. Market size and forecast

6.4. DRUG TESTING LABORATORIES

6.4.1. Market size and forecast

6.5. DRUG TREATMENT CENTERS

6.5.1. Market size and forecast

6.6. HOSPITALS

6.6.1. Market size and forecast

6.7. PERSONAL USERS

6.7.1. Market size and forecast

6.8. PAIN MANAGEMENT CENTERS

6.8.1. Market size and forecast

CHAPTER 7 DRUG SCREENING MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key Market Trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. UK market size and forecast
7.3.3.3. France market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Australia market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ALERE INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. DRAGERWERK AG & CO. KGAA

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. ABBOTT LABORATORIES

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. BIO-RAD LABORATORIES, INC.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. DANAHER CORPORATION

8.5.1. Company overview
8.5.2. Company Snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. EXPRESS DIAGNOSTICS INTERNATIONAL INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments

8.7. F. HOFFMANN-LA ROCHE AG (ROCHE DIAGNOSTICS)

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. QUEST DIAGNOSTICS INCORPORATED

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance

8.9. SIEMENS AKTIENGESELLSCHAFT

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. THERMO FISHER SCIENTIFIC INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2023 ($MILLION)
TABLE 2. DRUG SCREENING MARKET FOR EQUIPMENT, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. DRUG SCREENING MARKET FOR EQUIPMENT, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. DRUG SCREENING MARKET FOR IMMUNOASSAY ANALYZERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. DRUG SCREENING MARKET FOR CHROMATOGRAPHY INSTRUMENTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. DRUG SCREENING MARKET FOR BREATH ANALYZERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. DRUG SCREENING RAPID TESTING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 8. DRUG SCREENING MARKET FOR RAPID TESTING DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. DRUG SCREENING MARKET FOR URINE TESTING DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. U.S. DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS)
TABLE 11. U.S.MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016)
TABLE 12. CANADA DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS)
TABLE 13. CANADA MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016)
TABLE 14. UK DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS)
TABLE 15. UK MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016)
TABLE 16. TAIWAN DRUG SCREENING MARKET FOR URINE TESTING CUPS, BY VALUE AND VOLUME, 2016-2023 ($THOUSAND AND THOUSAND UNITS)
TABLE 17. TAIWAN MARKET SHARE ANALYSIS IN PERCENTAGE FOR URINE TESTING CUPS (2012-2016)
TABLE 18. DRUG SCREENING MARKET FOR ORAL FLUID TESTING DEVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL DRUG SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2016-2023 ($MILLION)
TABLE 20. DRUG SCREENING MARKET FOR CONSUMABLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. DRUG SCREENING MARKET FOR ASSAY KITS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. DRUG SCREENING MARKET FOR SAMPLE COLLECTION CUPS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. DRUG SCREENING MARKET FOR CALIBRATORS AND CONTROLS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. DRUG SCREENING MARKET FOR OTHERS CONSUMABLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 25. DRUG SCREENING MARKET FOR LABORATORY SERVICES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. GLOBAL DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION)
TABLE 27. DRUG SCREENING MARKET FOR URINE SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. DRUG SCREENING MARKET FOR ORAL FLUID SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 29. DRUG SCREENING MARKET FOR BREATH SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. DRUG SCREENING MARKET FOR HAIR SAMPLE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. DRUG SCREENING MARKET FOR OTHER SAMPLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 32. GLOBAL DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 33. DRUG SCREENING MARKET FOR WORKPLACE AND SCHOOLS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 34. DRUG SCREENING MARKET FOR CRIMINAL INVESTIGATION SERVICES & LAW ENFORCEMENT AGENCIES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 35. DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 36. DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 37. DRUG SCREENING MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 38. DRUG SCREENING MARKET FOR PERSONAL USERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 39. DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 40. NORTH AMERICA DRUG SCREENING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 41. NORTH AMERICA DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023, ($MILLION)
TABLE 42. NORTH AMERICA DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023, ($MILLION)
TABLE 43. NORTH AMERICA DRUG SCREENING MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 44. EUROPE DRUG SCREENING MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 45. EUROPE DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 ($MILLION)
TABLE 46. EUROPE DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION)
TABLE 47. EUROPE DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC DRUG SCREENING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 49. ASIA-PACIFIC DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 ($MILLION)
TABLE 50. ASIA-PACIFIC DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION)
TABLE 51. ASIA-PACIFIC DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 52. LAMEA DRUG SCREENING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 53. LAMEA DRUG SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 ($MILLION)
TABLE 54. LAMEA DRUG SCREENING MARKET, BY SAMPLE TYPE, 2016-2023 ($MILLION)
TABLE 55. LAMEA DRUG SCREENING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 56. ALERE: COMPANY SNAPSHOT
TABLE 57. ALERE: OPERATING SEGMENTS
TABLE 58. ALERE: PRODUCT PORTFOLIO
TABLE 59. DRAGER: COMPANY SNAPSHOT
TABLE 60. DRAGER: PRODUCT CATEGORIES
TABLE 61. DRAGER: PRODUCT PORTFOLIO
TABLE 62. ABBOTT: COMPANY SNAPSHOT
TABLE 63. ABBOTT: OPERATING SEGMENTS
TABLE 64. ABBOTT: PRODUCT PORTFOLIO
TABLE 65. BIO-RAD: COMPANY SNAPSHOT
TABLE 66. BIO-RAD: OPERATING SEGMENTS
TABLE 67. BIO-RAD: PRODUCT PORTFOLIO
TABLE 68. DANAHER: COMPANY SNAPSHOT
TABLE 69. DANAHER: OPERATING SEGMENTS
TABLE 70. DANAHER: PRODUCT PORTFOLIO
TABLE 71. EXPRESS DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 72. EXPRESS DIAGNOSTICS: OPERATING SEGMENTS
TABLE 73. ROCHE: COMPANY SNAPSHOT
TABLE 74. ROCHE: OPERATING SEGMENT
TABLE 75. ROCHE: PRODUCT PORTFOLIO
TABLE 76. QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 77. QUEST DIAGNOSTICS: OPERATING SEGMENTS
TABLE 78. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 79. SIEMENS: COMPANY SNAPSHOT
TABLE 80. SEIMENS: OPERATING SEGMENTS
TABLE 81. SIEMENS: PRODUCT PORTFOLIO
TABLE 82. THERMO FISHER: COMPANY SNAPSHOT
TABLE 83. THERMO FISHER: OPERATING SEGMENTS
TABLE 84. THERMO FISHER: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. GLOBAL DRUG SCREENING MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL DRUG SCREENING MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE AND DISTRIBUTION
FIGURE 4. TOP WINNING STRATEGIES: TYPE AND COMPANY
FIGURE 5. TOP WINNING STRATEGIES: TYPE AND NATURE
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. PATENT REGISTERED/APPROVED, BY YEAR (2010-2016)
FIGURE 12. PATENT REGISTERED/APPROVED, BY REGION (2010-2016)
FIGURE 13. GLOBAL DRUG SCREENING MARKET: DRIVERS & RESTRAINTS
FIGURE 14. DRUG SCREENING PRODUCT AND SERVICE SEGMENTATION
FIGURE 15. DRUG SCREENING SAMPLE TYPE SEGMENTATION
FIGURE 16. DRUG SCREENING MARKET END USER SEGMENTATION
FIGURE 17. U.S. DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 18. CANADA DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 19. MEXICO DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 20. GERMANY DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 21. UK DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 22. FRANCE DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 23. ITALY DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 24. REST OF EUROPE DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 25. JAPAN DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 26. CHINA DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 27. INDIA DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 28. AUSTRALIA DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 29. REST OF ASIA-PACIFIC DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 30. BRAZIL DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 31. TURKEY DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 32. SOUTH AFRICA DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 33. REST OF LAMEA DRUG SCREENING MARKET, 2016-2023 ($MILLION)
FIGURE 34. ALERE: NET SALES, 2014-2016 ($MILLION)
FIGURE 35. ALERE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 36. ALERE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 37. DRAGER: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. DRAGER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. BIO-RAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. BIO-RAD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 44. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 45. DANAHER: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. DANAHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 47. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 48. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. ROCHE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 50. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 51. QUEST DIAGNOSTICS: NET SALES, 2014-2016 ($MILLION)
FIGURE 52. QUEST DIAGNOSTICS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 53. SIEMENS: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. SIEMENS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 55. SIEMENS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 56. THERMO FISHER: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 58. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)